Skip to nav Skip to content
Laura  Oswald

Laura Oswald, PhD

Program: Health Outcomes and Behavior

Research Program: Health Outcomes & Behavior Program

Contact

  • Overview

    Dr. Oswald’s research focuses on developing and evaluating interventions to promote optimal psychosocial functioning among diverse cancer populations.

    Associations

    • Health Outcomes and Behavior
    • Health Outcomes & Behavior Program

    Education & Training

    Graduate:

    • University of Miami, PhD - Clinical Psychology
    • Saint Joseph's University, MS - Experimental Psychology

    Internship:

    • Rush University Medical Center - Health Psychology

    Fellowship:

    • Northwestern University Feinberg School of Medicine - T32 Behavioral and Psychosocial Research Training in Cancer Prevention and Control
  • Research Interest

    Dr. Oswald’s research focuses on developing and evaluating interventions to promote optimal psychosocial functioning among diverse cancer populations, assessing mechanisms through which interventions affect psychological and biological outcomes, and expanding the reach of evidence-based resources for enhancing coping and promoting quality of life throughout cancer survivorship via eHealth and mHealth platforms. 

  • Participating Trials

    Clinical Trial 22083
    Real-World Clinical and Patient-Reported Outcomes Among Patients With Relapsed/Refractory Multiple Myeloma treated With Commercial CAR-T Therapy
    Condition: Multiple Myeloma
    Status: Open

    Clinical Trial 22152
    Comparative effectiveness of Juntos Después del Cáncer (JDC) among Breast Cancer Survivors and their Intimate Partners
    Condition: Breast
    Status: Open

    If you believe you are eligible for one of these trials or studies, please call
    813-745-6100 or toll-free 1-800-679-0775.

  • Publications

    • Peres LC, Oswald LB, Dillard CM, De Avila G, Nishihori T, Blue BJ, Freeman CL, Locke FL, Alsina M, Castaneda Puglianini OA, Shune L, Sborov DW, Wagner C, Dima D, Hashmi H, Davis JA, Kocoglu MH, Badros AZ, Atrash S, Simmons G, Kalariya N, Ferreri CJ, Anderson LD, Afrough A, Kaur G, Lin Y, Liu L, Nadeem O, Voorhees PM, Khouri J, McGuirk JP, Sidana S, Hansen DK, Patel KK. Racial and ethnic differences in clinical outcomes among patients with multiple myeloma treated with CAR T-cell therapy. Blood Adv. 2024 Jan.8(1):251-259. Pubmedid: 37855718.
    • Post KE, Ahmad Z, Jankauskaite G, Centracchio J, Oswald L, Horick N, Park ER, Temel JS, Greer JA, Jacobs J. Managing Symptom Distress: Key Factors for Patients on Adjuvant Endocrine Therapy for Breast Cancer. J Pain Symptom Manag. 2024 Jan.67(1):88-97. Pubmedid: 37816436. Pmcid: PMC10842924.
    • Gudenkauf LM, Li X, Hoogland AI, Oswald LB, Lmanirad I, Permuth JB, Small BJ, Jim HSL, Rodriguez Y, Bryant CA, Zambrano KN, Walters KO, Reblin M, Gonzalez BD. Feasibility and acceptability of C-PRIME: A health promotion intervention for family caregivers of patients with colorectal cancer. Support Care Cancer. 2024 Feb.32(3):198. Pubmedid: 38416143.
    • Crowder SL, Li X, Himbert C, Viskochil R, Hoogland AI, Gudenkauf LM, Oswald LB, Gonzalez BD, Small BJ, Ulrich CM, Ose J, Peoples AR, Li CI, Shibata D, Toriola AT, Gigic B, Playdon MC, Hardikar S, Bower J, Siegel EM, Figueiredo JC, Jim HSL. Relationships Among Physical Activity, Sleep, and Cancer-related Fatigue: Results From the International ColoCare Study. Ann Behav Med. 2024 Feb.58(3):156-166. Pubmedid: 38141201. Pmcid: PMC10858307.
    • Aßmann ES, Ose J, Hathaway CA, Oswald LB, Hardikar S, Himbert C, Chellam V, Lin T, Daniels B, Kirchhoff AC, Gigic B, Grossman D, Tward J, Varghese TK, Shibata D, Figueiredo JC, Toriola AT, Beck A, Scaife C, Barnes CA, Matsen C, Ma DS, Colman H, Hunt JP, Jones KB, Lee CJ, Larson M, Onega T, Akerley WL, Li CI, Grady WM, Schneider M, Dinkel A, Islam JY, Gonzalez BD, Otto AK, Penedo FJ, Siegel EM, Tworoger SS, Ulrich CM, Peoples AR. Risk factors and health behaviors associated with loneliness among cancer survivors during the COVID-19 pandemic. J Behav Med. 2024 Feb. Pubmedid: 38418709.
    • Gudenkauf LM, Hathaway CA, Carroll JE, Small BJ, Li X, Hoogland AI, Castro E, Armaiz-Pena GN, Oswald LB, Jim HS, Tworoger SS, Gonzalez BD. Inequities in the Impacts of Hurricanes and other Extreme Weather Events for Cancer Survivors. Cancer Epidemiol Biomarkers Prev. 2024 Feb. Pubmedid: 38385842.
    • Smith KS, Hoogland AI, Welniak T, Nguyen OL, Rodriguez Y, Li X, Crowder SL, Oswald LB, Carpenter KM, Fischer SM, Li D, Kinney AY, Berry DL, Gonzalez BD, Jim HSL. Acute cancer-related symptoms and concerns among patients receiving chemotherapy: current state of the science. Support Care Cancer. 2024 Feb.32(3):184. Pubmedid: 38393418.
    • Oswald LB, Gudenkauf LM, Li X, De Avila G, Peres LC, Kirtane K, Gonzalez BD, Hoogland AI, Nguyen O, Rodriguez Y, Baz RC, Shain KH, Alsina M, Locke FL, Freeman C, Castaneda Puglianini O, Nishihori T, Liu H, Blue B, Grajales-Cruz A, Jim HSL, Hansen DK. Patient-Reported Outcomes among Multiple Myeloma Patients Treated with Standard of Care Idecabtagene Vicleucel. Cancers (Basel). 2023 Sep.15(19). Pubmedid: 37835405. Pmcid: PMC10571575.
    • Fox RS, Armstrong GE, Gaumond JS, Vigoureux TFD, Miller CH, Sanford SD, Salsman JM, Katsanis E, Badger TA, Reed DR, Gonzalez BD, Jim HSL, Warner EL, Victorson DE, Oswald LB. Social isolation and social connectedness among young adult cancer survivors: A systematic review. Cancer. 2023 Oct.129(19):2946-2965. Pubmedid: 37489837. Pmcid: PMC10584376.
    • Li X, Hoogland AI, Small BJ, Crowder SL, Gonzalez BD, Oswald LB, Sleight AG, Nguyen N, Lorona NC, Damerell V, Komrokji KR, Mooney K, Playdon MC, Ulrich CM, Li CI, Shibata D, Toriola AT, Ose J, Peoples AR, Siegel EM, Bower JE, Schneider M, Gigic B, Figueiredo JC, Jim HSL. Trajectories and risk factors of fatigue following colorectal cancer diagnosis. Colorectal Dis. 2023 Oct.25(10):2054-2063. Pubmedid: 37700526.
    • Hyland KA, Oswald LB, Reblin M, Small BJ, Gray JE, Jim HSL, Jacobsen PB. Goals and goal perceptions in patients with advanced stage lung cancer: a mixed methods study. Support Care Cancer. 2023 May.31(5):314. Pubmedid: 37126099. Pmcid: PMC10150146.
    • Patel KB, Alishahi Tabriz A, Turner K, Gonzalez BD, Oswald LB, Jim HSL, Nguyen OT, Hong YR, Aldawoodi N, Cao B, Wang X, Rollison DE, Robinson EJ, Naso C, Spiess PE. Telemedicine Adoption in an NCI-Designated Cancer Center During the COVID-19 Pandemic: A Report on Patient Experience of Care. J Natl Compr Canc Ne. 2023 May.21(5):496-502.e6. Pubmedid: 37156477.
    • Schumacher FA, Helenowski IB, Sun Z, Oswald LB, Gonzalez BD, Moses KA, Benning JT, Morgans AK. Treatment decision-making among patients with metastatic prostate cancer: Impact of decision locus of control on functional outcomes and decision satisfaction. Prostate Cancer P D. 2023 Mar.26(1):201-206. Pubmedid: 36709235.
    • Turner K, Stover AM, Tometich DB, Geiss C, Mason A, Nguyen OT, Hume E, McCormick R, Powell S, Hallanger-Johnson J, Patel KB, Kirtane KS, Jammigumpula N, Moore C, Perkins R, Rollison DE, Jim HSL, Oswald LB, Crowder S, Gonzalez BD, Robinson E, Tabriz AA, Islam JY, Gilbert SM. Oncology Providers' and Professionals' Experiences With Suicide Risk Screening Among Patients With Head and Neck Cancer: A Qualitative Study. JCO Oncol Pract. 2023 Jun.19(6):e892-e903. Pubmedid: 36395441. Pmcid: PMC10337750.
    • Gudenkauf LM, Chavez M, Maconi ML, Geiss C, Seyedroudbari A, Thin P, Hoogland AI, Nguyen K, Murthy V, Armstrong WR, Komrokji K, Oswald LB, Jim HSL, El-Haddad G, Fendler WP, Herrmann K, Cella D, Czernin J, Hofman MS, Dicker AP, Calais J, Tagawa ST, Gonzalez BD. Developing a Patient-Reported Outcome Measure for Radionuclide Therapy for Prostate Cancer. J Nucl Med. 2023 Jun.64(6):869-872. Pubmedid: 36635088. Pmcid: PMC10241017.
    • Li X, Roy S, Damonte J, Park HY, Hoogland AI, Jamison K, Komrokji KR, Yeo CD, Kim Y, Dhillon J, Gudenkauf LM, Oswald LB, Jim HSL, Yamoah K, Pow-Sang JM, Kanetsky PA, Gwede CK, Park JY, Gonzalez BD. Recruiting African American Prostate Cancer Survivors for a Population-based Biobank Study. Cancer Epidemiol Biomarkers Prev. 2023 Jun.32(6):768-775. Pubmedid: 36958853. Pmcid: PMC10308568.
    • Hoogland AI, Small BJ, Oswald LB, Bryant C, Rodriguez Y, Gonzalez BD, Li X, Janelsins MC, Bulls HW, James BW, Arboleda B, Colon-Echevarria C, Townsend MK, Tworoger SS, Rodriguez PC, Bower JE, Apte SM, Wenham RM, Jim HSL. Relationships among Inflammatory Biomarkers and Self-Reported Treatment-Related Symptoms in Patients Treated with Chemotherapy for Gynecologic Cancer: A Controlled Comparison. Cancers (Basel). 2023 Jun.15(13). Pubmedid: 37444517. Pmcid: PMC10340589.
    • Tometich DB, Hoogland AI, Small BJ, Janelsins MC, Bryant C, Rodriguez Y, Gonzalez BD, Li X, Bulls HW, James BW, Arboleda B, Colon-Echevarria C, Townsend MK, Tworoger SS, Rodriguez P, Oswald LB, Bower JE, Apte SM, Wenham RM, Chon HS, Shahzad MM, Jim HSL. Relationships among Inflammatory Biomarkers and Objectively Assessed Physical Activity and Sleep during and after Chemotherapy for Gynecologic Malignancies. Cancers (Basel). 2023 Jul.15(15). Pubmedid: 37568698. Pmcid: PMC10416903.
    • Buro AW, Carson TL, Small BJ, Fan W, Oswald LB, Jim HSL, Salas E, Zambrano K, Bryant C, Yamoah K, Gwede CK, Park JY, Gonzalez BD. Sociocultural factors associated with physical activity in Black prostate cancer survivors. Support Care Cancer. 2023 Jul.31(8):482. Pubmedid: 37479918. Pmcid: PMC10388711.
    • Kirtane K, Hoogland AI, Li X, Rodriguez Y, Scheel K, Small BJ, Oswald LB, Muzaffar J, Kish JA, Bonomi M, Bhateja P, Saba NF, Steuer CE, Chung CH, Jim HSL. Patient-reported outcomes in immunotherapy for head and neck cancer. Head Neck. 2023 Jul.45(7):1761-1771. Pubmedid: 37141438.
    • Benzo RM, Moreno PI, Fox RS, Silvera CA, Walsh EA, Yanez B, Balise RR, Oswald LB, Penedo FJ. Comorbidity burden and health-related quality of life in men with advanced prostate cancer. Support Care Cancer. 2023 Jul.31(8):496. Pubmedid: 37501020.
    • Patel KB, Turner K, Alishahi Tabriz A, Gonzalez BD, Oswald LB, Nguyen OT, Hong YR, Jim HSL, Nichols AC, Wang X, Robinson E, Naso C, Spiess PE. Estimated Indirect Cost Savings of Using Telehealth Among Nonelderly Patients With Cancer. JAMA Netw Open. 2023 Jan.6(1):e2250211. Pubmedid: 36626174. Pmcid: PMC9856804.
    • Kirtane K, Reblin M, Oswald LB, Irizarry-Arroyo N, McCormick R, Locke FL, Ketcher D. Psychosocial characteristics of patients undergoing cellular immunotherapies and their caregivers across time. Leuk Lymphoma. 2023 Feb.64(2):364-370. Pubmedid: 36416677. Pmcid: PMC10329860.
    • Benzo R, Moreno PI, Fox RS, Silvera CA, Walsh EA, Yanez B, Balise RR, Oswald LB, Penedo FJ. Comorbidity burden and health-related quality of life in men with advanced prostate cancer. Res Sq. 2023 Feb. Pubmedid: 36824747. Pmcid: PMC9949262.
    • Oswald LB, Venditti A, Cella D, Cottone F, Candoni A, Melillo L, Cairoli R, Storti G, Salutari P, Luppi M, Albano F, Martelli MP, Cuneo A, Tafuri A, Trisolini SM, Tieghi A, Fazi P, Vignetti M, Efficace F. Fatigue in newly diagnosed acute myeloid leukaemia: general population comparison and predictive factors. BMJ Support Palliat Care. 2023 Dec.13(e2):e344-e351. Pubmedid: 33941573. Pmcid: PMC8563490.
    • Lee DH, Kumar A, Mohammed T, Peres LC, Alsina M, Bachmeier CA, Blue B, Brayer J, Chandrasekhar S, Grajales-Cruz AF, De Avila G, Elmariah H, Faramand RG, Freeman CL, Jain MD, Khadka S, Khimani F, Liu H, Nishihori T, Oswald LB, Castaneda Puglianini OA, Shain KH, Smith E, Baz RC, Locke FL, Oliveira GH, Alomar M, Hansen DK. Cardiac events after standard of care idecabtagene vicleucel for relapsed and refractory multiple myeloma. Blood Adv. 2023 Aug.7(16):4247-4257. Pubmedid: 37307173. Pmcid: PMC10424134.
    • Peoples AR, Oswald LB, Ose J, Daniels B, Himbert C, Hathaway CA, Gigic B, Kirchhoff AC, Lin T, Grossman D, Tward J, Varghese TK, Figueiredo JC, Toriola AT, Beck A, Scaife C, Shibata D, LaStayo P, Gonzalez B, Salas K, Ashworth A, Matsen C, Christenson C, Ma DS, Colman H, Hunt JP, Jones KB, Lee CJ, Larson M, Onega T, Akerley WL, Li CI, Schneider M, Penedo FJ, Siegel EM, Tworoger SS, Ulrich CM. Impact of the COVID-19 pandemic on rural and urban cancer patients' experiences, health behaviors, and perceptions. J Rural Health. 2022 Sep.38(4):886-899. Pubmedid: 35243690. Pmcid: PMC9115146.
    • Oswald LB, Arredondo B, Geiss C, Vigoureux TFD, Hoogland AI, Chung CH, Muzaffar J, Patel KB, Gonzalez BD, Jim HSL, Kirtane K. Considerations for developing supportive care interventions for survivors of head and neck cancer: A qualitative study. Psychooncology. 2022 Sep.31(9):1519-1526. Pubmedid: 35726386. Pmcid: PMC9452460.
    • Oswald LB, Fox RS, Murphy KM, Salsman JM, Sanford SD, McDade TW, Victorson DE. Preliminary Effects of Mindfulness Training on Inflammatory Markers and Blood Pressure in Young Adult Survivors of Cancer: Secondary Analysis of a Pilot Randomized Controlled Trial. Int J Behav Med. 2022 Oct.29(5):676-684. Pubmedid: 35048316. Pmcid: PMC9296689.
    • Geiss C, Chavez MN, Oswald LB, Ketcher D, Reblin M, Bandera EV, Savard J, Zhou ES, Fox RS, Jim HSL, Gonzalez BD. "I Beat Cancer to Feel Sick:" Qualitative Experiences of Sleep Disturbance in Black Breast Cancer Survivors and Recommendations for Culturally Targeted Sleep Interventions. Ann Behav Med. 2022 Nov.56(11):1110-1115. Pubmedid: 35759312. Pmcid: PMC9635993.
    • Hathaway CA, Siegel EM, Gonzalez BD, Oswald LB, Peoples AR, Ulrich CM, Penedo FJ, Tworoger SS, Islam JY. Individual-level factors associated with COVID-19 vaccine acceptance among U.S. patients with cancer. Vaccine. 2022 Nov.40(46):6649-6657. Pubmedid: 36210253. Pmcid: PMC9515327.
    • Oswald LB, Eisel SL, Tometich DB, Bryant C, Hoogland AI, Small BJ, Apte SM, Chon HS, Shahzad MM, Gonzalez BD, Jim HSL. Cumulative burden of symptomatology in patients with gynecologic malignancies undergoing chemotherapy. Health Psychol. 2022 Nov.41(11):864-873. Pubmedid: 35901399. Pmcid: PMC9588549.
    • Oswald LB, Li X, Carvajal R, Hoogland AI, Gudenkauf LM, Hansen DK, Alsina M, Locke FL, Rodriguez Y, Irizarry-Arroyo N, Robinson EJ, Jim HSL, Gonzalez BD, Kirtane K. Longitudinal Collection of Patient-Reported Outcomes and Activity Data during CAR-T Therapy: Feasibility, Acceptability, and Data Visualization. Cancers (Basel). 2022 May.14(11). Pubmedid: 35681722. Pmcid: PMC9179384.
    • Kirtane KS, Jim HS, Gonzalez BD, Oswald LB. Promise of Patient-Reported Outcomes, Biometric Data, and Remote Monitoring for Adoptive Cellular Therapy. JCO Clin Cancer Inform. 2022 May.6:e2200013. Pubmedid: 35561286.
    • Kirtane K, Geiss C, Arredondo B, Hoogland AI, Chung CH, Muzaffar J, Patel KB, Gonzalez BD, Jim HSL, Oswald LB. "I have cancer during COVID; that's a special category": a qualitative study of head and neck cancer patient and provider experiences during the COVID-19 pandemic. Support Care Cancer. 2022 May.30(5):4337-4344. Pubmedid: 35091844. Pmcid: PMC8799415.
    • Oswald LB, Brownstein NC, Whiting J, Hoogland AI, Saravia S, Kirtane K, Chung CH, Vinci C, Gonzalez BD, Johnstone PAS, Jim HSL. Smoking Is Related to Worse Cancer-related Symptom Burden. Oncologist. 2022 Mar.27(2):e176-e184. Pubmedid: 35641215. Pmcid: PMC8895733.
    • Oswald LB, Morales-Cruz J, Eisel SL, Del Rio J, Hoogland AI, Ortiz-Rosado V, Soto-Lopez G, Rodriguez-Rivera E, Savard J, Castro E, Jim HSL, Gonzalez BD. Pilot randomized controlled trial of eHealth cognitive-behavioral therapy for insomnia among Spanish-speaking breast cancer survivors. J Behav Med. 2022 Jun.45(3):503-508. Pubmedid: 35438442. Pmcid: PMC9016697.
    • Gonzalez BD, Eisel SL, Bowles KE, Hoogland AI, James BW, Small BJ, Sharpe S, Hyland KA, Bulls HW, Christy SM, Mansfield J, Nelson AM, Alla R, Maharaj K, Kennedy B, Lafranchise E, Williams NL, Jennewein S, Oswald LB, Postow MA, Dicker AP, Jim HSL. Meta-Analysis of Quality of Life in Cancer Patients Treated With Immune Checkpoint Inhibitors. J Natl Cancer Inst. 2022 Jun.114(6):808-818. Pubmedid: 34508604. Pmcid: PMC9194633.
    • Barata A, Hoogland AI, Kommalapati A, Logue J, Welniak T, Hyland KA, Eisel SL, Small BJ, Jayani RV, Booth-Jones M, Oswald LB, Gonzalez BD, Kirtane KS, Jain MD, Mokhtari S, Chavez JC, Lazaryan A, Shah BD, Locke FL, Jim HSL. Change in Patients' Perceived Cognition Following Chimeric Antigen Receptor T-Cell Therapy for Lymphoma. Transplant Cell Ther. 2022 Jul.28(7):401.e1-401.e7. Pubmedid: 35580732. Pmcid: PMC9339228.
    • Schumacher FA, Helenowski IB, Oswald LB, Gonzalez BD, Benning JT, Morgans AK. Treatment Decision-Making in Metastatic Prostate Cancer: Perceptions of Locus of Control Among Patient, Caregiver, and Physician Triads. Patient Prefer Adherence. 2022 Jan.16:235-244. Pubmedid: 35125865. Pmcid: PMC8811793.
    • Oswald LB, Hyland KA, Eisel SL, Hoogland AI, Knoop H, Nelson AM, Pinilla-Ibarz J, Sweet K, Jacobsen PB, Jim HSL. Correlates of fatigue severity in patients with chronic myeloid leukemia treated with targeted therapy. Support Care Cancer. 2022 Jan.30(1):87-94. Pubmedid: 34231041. Pmcid: PMC8639627.
    • Turner K, Bobonis Babilonia M, Naso C, Nguyen O, Gonzalez BD, Oswald LB, Robinson E, Elston Lafata J, Ferguson RJ, Alishahi Tabriz A, Patel K, Hallanger-Johnson J, Aldawoodi N, Hong YR, Jim HSL, Speiss PE. Health Care Providers' and Professionals' Experiences With Telehealth Oncology Implementation During the COVID-19 Pandemic: A Qualitative Study. J Med Internet Res. 2022 Jan.24(1):e29635. Pubmedid: 34907900. Pmcid: PMC8772877.
    • Turner K, Brownstein NC, Thompson Z, El Naqa I, Luo Y, Jim HSL, Rollison DE, Howard R, Zeng D, Rosenberg SA, Perez B, Saltos A, Oswald LB, Gonzalez BD, Islam JY, Alishahi Tabriz A, Zhang W, Dilling TJ. Longitudinal patient-reported outcomes and survival among early-stage non-small cell lung cancer patients receiving stereotactic body radiotherapy. Radiother Oncol. 2022 Feb.167:116-121. Pubmedid: 34953934. Pmcid: PMC8934278.
    • Jim H, Oswald L. Patient-reported outcomes: important data in early trials of novel therapies. Lancet Haematol. 2022 Dec.9(12):e866-e868. Pubmedid: 36215987.
    • Oswald LB, Lyleroehr M, Gudenkauf LM, Armstrong GE, Tometich DB, Sanford SD, Loecher N, Geiss C, Rodriguez Y, Scheel KL, Nieves-Lopez A, Jim HSL, Gonzalez BD, Antoni MH, Penedo FJ, Reed D, Katsanis E, Salsman JM, Victorson D, Fox RS. Development and initial testing of TOGETHER-YA: an eHealth-delivered and group-based psychosocial intervention for young adult cancer survivors. Support Care Cancer. 2022 Dec.30(12):10067-10076. Pubmedid: 36229547. Pmcid: PMC9722531.
    • Hathaway CA, Bloomer AM, Oswald LB, Siegel EM, Peoples AR, Ulrich CM, Penedo FJ, Tworoger SS, Gonzalez BD. Factors associated with self-reported social isolation among patients with cancer during the COVID-19 pandemic. Health Psychol. 2022 Apr.41(4):311-318. Pubmedid: 35324248. Pmcid: PMC9053063.
    • Yanez B, Oswald LB, Van Denburg AN, Baik SH, Czech KA, Buitrago D, Maletich C, Wortman K, Penedo FJ, Victorson DE. Rationale and usability findings of an e-health intervention to improve oral anticancer adherence among breast cancer survivors: The My Journey mindfulness study. Contemp Clin Trials Commun. 2022 Apr.26:100898. Pubmedid: 35252622. Pmcid: PMC8889091.
    • Oswald LB, Baik SH, Buscemi J, Buitrago D, Iacobelli F, Guitelman J, Penedo FJ, Yanez B. Effects of smartphone interventions on cancer knowledge and coping among Latina breast cancer survivors: Secondary analysis of a pilot randomized controlled trial. J Psychosoc Oncol. 2021 Oct.40(6):695-707. Pubmedid: 34620035. Pmcid: PMC8986885.
    • Safa H, Tamil M, Spiess PE, Manley B, Pow-Sang J, Gilbert S, Safa F, Gonzalez BD, Oswald LB, Semaan A, Diab A, Chahoud J. Patient-Reported Outcomes in Clinical Trials Leading to Cancer Immunotherapy Drug Approvals From 2011 to 2018: A Systematic Review. J Natl Cancer Inst. 2021 May.113(5):532-542. Pubmedid: 33146385. Pmcid: PMC8096374.
    • Oswald LB, Victorson DE, Fox RS. Young adult cancer survivors' preferences for supportive interventions. Psychooncology. 2021 Jun.30(6):982-985. Pubmedid: 33624384. Pmcid: PMC8284553.
    • Oswald LB, Arredondo B, Kadono M, Martinez-Tyson D, Meade CD, Penedo F, Antoni MH, Soliman H, Costa RLB, Jim HSL. A mixed-methods study of cyclin-dependent kinase 4 and 6 inhibitor symptom burden and quality of life among metastatic breast cancer patients and providers. Cancer Med. 2021 Jul.10(14):4823-4831. Pubmedid: 34165265. Pmcid: PMC8290228.
    • Penedo FJ, Fox RS, Walsh EA, Yanez B, Miller GE, Oswald LB, Estabrook R, Chatterton RT, Mohr DC, Begale MJ, Flury SC, Perry K, Kundu SD, Moreno PI. Effects of web-based cognitive behavioral stress management and health promotion interventions on neuroendocrine and inflammatory markers in men with advanced prostate cancer: A randomized controlled trial. Brain Behav Immun. 2021 Jul.95:168-177. Pubmedid: 33737170. Pmcid: PMC8888023.
    • Fox RS, Oswald LB, Fowler B, Carrera JB, Reichek J, Victorson D, Sanford SD. Understanding and Enhancing Support Group Participation Among Adolescent and Young Adult Cancer Survivors: The Impact of Integrating Adolescent and Young Adult Cancer Navigation Services. J Adolesc Young Adult Oncol. 2021 Aug.10(4):488-492. Pubmedid: 33275855.
    • Efficace F, Cottone F, Oswald LB, Cella D, Patriarca A, Niscola P, Breccia M, Platzbecker U, Palumbo GA, Caocci G, Stauder R, Ricco A, Petranovic D, Caers J, Luppi M, Fianchi L, Frairia C, Capodanno I, Follini E, Sarlo C, Fazi P, Vignetti M. The IPSS-R more accurately captures fatigue severity of newly diagnosed patients with myelodysplastic syndromes compared with the IPSS index. Leukemia. 2020 Sep.34(9):2451-2459. Pubmedid: 32086447. Pmcid: PMC7509847.
    • Oswald LB, Schumacher FA, Gonzalez BD, Moses KA, Penson DF, Morgans AK. What Do Men with Metastatic Prostate Cancer Consider When Making Treatment Decisions? A Mixed-methods Study. Patient Prefer Adherence. 2020 Oct.14:1949-1959. Pubmedid: 33116438. Pmcid: PMC7569052.
    • Penedo FJ, Fox RS, Oswald LB, Moreno PI, Boland CL, Estabrook R, McGinty HL, Mohr DC, Begale MJ, Dahn JR, Flury SC, Perry KT, Kundu SD, Yanez B. Technology-Based Psychosocial Intervention to Improve Quality of Life and Reduce Symptom Burden in Men with Advanced Prostate Cancer: Results from a Randomized Controlled Trial. Int J Behav Med. 2020 Oct.27(5):490-505. Pubmedid: 31898309. Pmcid: PMC7587609.
    • Buscemi J, Oswald LB, Baik SH, Buitrago D, Iacobelli F, Phillips SM, Perez-Tamayo A, Guitelman J, Penedo FJ, Yanez B. My health smartphone intervention decreases daily fat sources among Latina breast cancer survivors. J Behav Med. 2020 Oct.43(5):732-742. Pubmedid: 31970652. Pmcid: PMC7374026.
    • Penedo FJ, Oswald LB, Kronenfeld JP, Garcia SF, Cella D, Yanez B. The increasing value of eHealth in the delivery of patient-centred cancer care. Lancet Oncol. 2020 May.21(5):e240-e251. Pubmedid: 32359500. Pmcid: PMC7643123.
    • Peipert JD, Badawy SM, Baik SH, Oswald LB, Efficace F, Garcia SF, Mroczek DK, Wolf M, Kaiser K, Yanez B, Cella D. Development of the NIH Patient-Reported Outcomes Measurement Information System (PROMIS) Medication Adherence Scale (PMAS). Patient Prefer Adherence. 2020 Jun.14:971-983. Pubmedid: 32606615. Pmcid: PMC7293395.
    • Hooker SA, Oswald LB, Reid KJ, Baron KG. Do Physical Activity, Caloric Intake, and Sleep Vary Together Day to Day? Exploration of Intraindividual Variability in 3 Key Health Behaviors. J Phys Act Health. 2020 Jan.17(1):45-51. Pubmedid: 31756722. Pmcid: PMC7211555.
    • Yanez B, Oswald LB, Baik SH, Buitrago D, Iacobelli F, Perez-Tamayo A, Guitelman J, Penedo FJ, Buscemi J. Brief culturally informed smartphone interventions decrease breast cancer symptom burden among Latina breast cancer survivors. Psychooncology. 2020 Jan.29(1):195-203. Pubmedid: 31693265. Pmcid: PMC7008945.
    • Oswald LB, Kasimer R, Rappazzo K, Fought AJ, Penson DF, Morgans AK. Patient expectations of benefit from systemic treatments for metastatic prostate cancer. Cancer Med. 2020 Feb.9(3):980-987. Pubmedid: 31840434. Pmcid: PMC6997053.
    • Tometich DB, Hyland KA, Soliman H, Jim HSL, Oswald L. Living with Metastatic Cancer: A Roadmap for Future Research. Cancers (Basel). 2020 Dec.12(12). Pubmedid: 33302472. Pmcid: PMC7763639.
    • Oswald LB, Lee JW, Argiris A, Webster KA, Forastiere AA, Cella D. Validation of brief symptom indexes among patients with recurrent or metastatic squamous cell carcinoma of the head and neck: A trial of the ECOG-ACRIN Cancer Research Group (E1302). Cancer Med. 2020 Dec.9(23):8884-8894. Pubmedid: 33040481. Pmcid: PMC7724483.
    • Baik SH, Oswald LB, Buscemi J, Buitrago D, Iacobelli F, Perez-Tamayo A, Guitelman J, Penedo FJ, Yanez B. Patterns of Use of Smartphone-Based Interventions Among Latina Breast Cancer Survivors: Secondary Analysis of a Pilot Randomized Controlled Trial. JMIR Cancer. 2020 Dec.6(2):e17538. Pubmedid: 33289669. Pmcid: PMC7755528.
    • Baik SH, Oswald LB, Buitrago D, Buscemi J, Iacobelli F, Perez-Tamayo A, Guitelman J, Diaz A, Penedo FJ, Yanez B. Cancer-Relevant Self-Efficacy Is Related to Better Health-Related Quality of Life and Lower Cancer-Specific Distress and Symptom Burden Among Latina Breast Cancer Survivors. Int J Behav Med. 2020 Aug.27(4):357-365. Pubmedid: 32394220. Pmcid: PMC7518020.
    • Fox RS, Moreno PI, Yanez B, Estabrook R, Thomas J, Bouchard LC, McGinty HL, Mohr DC, Begale MJ, Flury SC, Perry KT, Kundu SD, Penedo FJ. Integrating PROMIS® computerized adaptive tests into a web-based intervention for prostate cancer. Health Psychol. 2019 May.38(5):403-409. Pubmedid: 31045423. Pmcid: PMC6546285.
    • Bouchard LC, Yanez B, Dahn JR, Flury SC, Perry KT, Mohr DC, Penedo FJ. Brief report of a tablet-delivered psychosocial intervention for men with advanced prostate cancer: Acceptability and efficacy by race. Transl Behav Med. 2019 Jul.9(4):629-637. Pubmedid: 30285186. Pmcid: PMC7184868.
    • Bouchard LC, Fisher HM, Carver CS, Kim Y, Antoni MH. Social comparisons predict health-related quality of life and depressive symptoms across the first year of breast cancer treatment. Psychooncology. 2019 Feb.28(2):386-393. Pubmedid: 30501015. Pmcid: PMC6545917.
    • Yanez B, Baik SH, Oswald LB, Buitrago D, Buscemi J, Iacobelli F, Perez-Tamayo A, Fajardo P, Serrano G, Guitelman J, Penedo FJ. An Electronic Health Intervention for Latina Women Undergoing Breast Cancer Treatment (My Guide for Breast Cancer Treatment): Protocol for a Randomized Controlled Trial. JMIR Res Protoc. 2019 Dec.8(12):e14339. Pubmedid: 31833834. Pmcid: PMC6935046.
    • Oswald LB, Guitelman J, Buitrago D, Buscemi J, Iacobelli F, Perez-Tamayo A, Penedo F, Yanez B. Community Perspectives: Developing and Implementing a Smartphone Intervention for Latina Breast Cancer Survivors in Chicago. Prog Community Health Partnersh. 2019 Aug.13(5):131-136. Pubmedid: 31378743. Pmcid: PMC6894161.
    • Yanez B, Bouchard LC, Cella D, Sosman JA, Kircher SM, Mohindra NA, Cristofanilli M, Penedo FJ. Patient-centered engagement and symptom/toxicity monitoring in the new era of tumor next-generation sequencing and immunotherapy: The OncoTool and OncoPRO platforms. Cancer. 2019 Apr. Pubmedid: 31034599.
    • Wang AW, Bouchard LC, Gudenkauf LM, Jutagir DR, Fisher HM, Jacobs JM, Blomberg BB, Lechner SC, Carver CS, Antoni MH. Differential psychological effects of cognitive-behavioral stress management among breast cancer patients with high and low initial cancer-specific distress. J Psychosom Res. 2018 Oct.113:52-57. Pubmedid: 30190048. Pmcid: PMC6130907.
    • Lillis TA, Gerhart J, Bouchard LC, Cvengros J, O'Mahony S, Kopkash K, Kabaker KB, Burns J. Sleep Disturbance Mediates the Association of Post-Traumatic Stress Disorder Symptoms and Pain in Patients With Cancer. Am J Hosp Palliat Care. 2018 May.35(5):788-793. Pubmedid: 29084448. Pmcid: PMC6200422.
    • Bouchard LC, Aaronson N, Gondek K, Cella D. Cancer symptom response as an oncology clinical trial end point. Expert Rev Qual Life Cancer Care. 2018 May.3(2-3):35-46. Pubmedid: 31020045. Pmcid: PMC6476191.
    • Buscemi J, Buitrago D, Iacobelli F, Penedo F, Maciel C, Guitleman J, Balakrishnan A, Corden M, Adler RF, Bouchard LC, Perez-Tamayo A, Yanez BR. Feasibility of a Smartphone-based pilot intervention for Hispanic breast cancer survivors: a brief report. Transl Behav Med. 2018 Jul. Pubmedid: 29986120.
    • Antoni MH, Jacobs JM, Bouchard LC, Lechner SC, Jutagir DR, Gudenkauf LM, Blomberg BB, Glück S, Carver CS. Post-surgical depressive symptoms and long-term survival in non-metastatic breast cancer patients at 11-year follow-up. Gen Hosp Psychiat. 2017 Jan.44:16-21. Pubmedid: 28041571. Pmcid: PMC5215933.
    • Jutagir DR, Blomberg BB, Carver CS, Lechner SC, Timpano KR, Bouchard LC, Gudenkauf LM, Jacobs JM, Diaz A, Lutgendorf SK, Cole SW, Heller AS, Antoni MH. Social well-being is associated with less pro-inflammatory and pro-metastatic leukocyte gene expression in women after surgery for breast cancer. Breast Cancer Res Treat. 2017 Aug.165(1):169-180. Pubmedid: 28560656. Pmcid: PMC5528864.
    • Jutagir DR, Gudenkauf LM, Stagl JM, Carver CS, Bouchard LC, Lechner SC, Glück S, Blomberg BB, Antoni MH. Ethnic differences in types of social support from multiple sources after breast cancer surgery. Ethn Health. 2016 Oct.21(5):411-425. Pubmedid: 26218189. Pmcid: PMC4731323.
    • Bouchard LC, Antoni MH, Blomberg BB, Stagl JM, Gudenkauf LM, Jutagir DR, Diaz A, Lechner S, Glück S, Derhagopian RP, Carver CS. Postsurgical Depressive Symptoms and Proinflammatory Cytokine Elevations in Women Undergoing Primary Treatment for Breast Cancer. Psychosom Med. 2016 Jan.78(1):26-37. Pubmedid: 26569533. Pmcid: PMC4696897.
    • Antoni MH, Bouchard LC, Jacobs JM, Lechner SC, Jutagir DR, Gudenkauf LM, Carver CS, Lutgendorf S, Cole SW, Lippman M, Blomberg BB. Stress management, leukocyte transcriptional changes and breast cancer recurrence in a randomized trial: An exploratory analysis. Psychoneuroendocrinology. 2016 Dec.74:269-277. Pubmedid: 27689900. Pmcid: PMC5159236.
    • Stagl JM, Lechner SC, Carver CS, Bouchard LC, Gudenkauf LM, Jutagir DR, Diaz A, Yu Q, Blomberg BB, Ironson G, Glück S, Antoni MH. A randomized controlled trial of cognitive-behavioral stress management in breast cancer: survival and recurrence at 11-year follow-up. Breast Cancer Res Treat. 2015 Nov.154(2):319-328. Pubmedid: 26518021. Pmcid: PMC5752103.
    • Stagl JM, Bouchard LC, Lechner SC, Blomberg BB, Gudenkauf LM, Jutagir DR, Glück S, Derhagopian RP, Carver CS, Antoni MH. Long-term psychological benefits of cognitive-behavioral stress management for women with breast cancer: 11-year follow-up of a randomized controlled trial. Cancer. 2015 Jun.121(11):1873-1881. Pubmedid: 25809235. Pmcid: PMC4441540.
    • Hall DL, Antoni MH, Lattie EG, Jutagir DR, Czaja SJ, Perdomo D, Lechner SC, Stagl JM, Bouchard LC, Gudenkauf LM, Traeger L, Fletcher M, Klimas NG. Perceived Fatigue Interference and Depressed Mood: Comparison of Chronic Fatigue Syndrome/Myalgic Encephalomyelitis Patients with Fatigued Breast Cancer Survivors. Fatigue. 2015 Jul.3(3):142-155. Pubmedid: 26180660. Pmcid: PMC4500199.
    • Stagl JM, Antoni MH, Lechner SC, Bouchard LC, Blomberg BB, Glück S, Derhagopian RP, Carver CS. Randomized controlled trial of cognitive behavioral stress management in breast cancer: a brief report of effects on 5-year depressive symptoms. Health Psychol. 2015 Feb.34(2):176-180. Pubmedid: 25068452. Pmcid: PMC5761723.
    • Gudenkauf LM, Antoni MH, Stagl JM, Lechner SC, Jutagir DR, Bouchard LC, Blomberg BB, Glück S, Derhagopian RP, Giron GL, Avisar E, Torres-Salichs MA, Carver CS. Brief cognitive-behavioral and relaxation training interventions for breast cancer: A randomized controlled trial. J Consult Clin Psychol. 2015 Aug.83(4):677-688. Pubmedid: 25939017. Pmcid: PMC4516670.
  • Grants

    • Title: Real-world Clinical and Patient-reported Outcomes among Patients with Relapsed/refractory Multiple Myeloma Treated with Commercial CAR-T Therapy
      Sponsor: Moffitt Cancer Center
      PI (Contact): Hansen, D., PI: Oswald, L., PI: Peres, L.
    • Title: Culturally Adapted Online Couples Communication Program for Latina Breast Cancer Patients
      Sponsor: Patient Ctr Outcomes Research Institute (PCORI)
      PI: Oswald, L.

Find a Researcher Search